Terapevticheskii arkhivTerapevticheskii arkhiv0040-36602309-5342LLC Obyedinennaya Redaktsiya31033Research ArticleHCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITISVasilievV I-PalshinaS Gvitalana@mail.ruLogvinenkoO Aoksanalogv@yandex.ruSafonovaT N-RodionovaE B-VarlamovaE J-NekrasovaT P-Radenska-LopovokS G-ProbatovaN A-AlexandrovaE Nirramn@rambler.ruNasonovE Lsokrat@irramn.ruResearch Institute of Rheumatology of RAMSResearch Institute of Ophthalmology of RAMSHematological Research Center of RAMSI.M. Sechenov First Medical UniversityN.N. Blokhin Russian Cancer Research Center of RAMS15052012845354210042020Copyright © 2012, Consilium Medicum2012Aim. To analyze clinical and laboratory features of cryoglobulinemic vasculitis (CGEV) associated with HCV infection. Material and methods. We examined 61 patients with clinical manifestation of CGEV in 2006-2011. CGEV was associated with autoimmune diseases in 31 patients (51 %), with HCV infection in 21 patients (34,4 %), essential (idiopathic) cryoglobulinemia in 8 patients (13 %) and lymphoproliferative diseases in 1 patient (1,6 %). 21 patients with HCV-associated CGEV were studied for main clinical and laboratory manifestations of the disease. Kidney and liver involvement was confirmed morphologically and immunomorphologically. Electroneurophysiological investigation evaluated peripheral nervous system involvement. Biopsy of parotid, lacrimal glands, peripheral lymph nodes, splenectomy and bone marrow trephine biopsy with morphological study and immunohistochemistry were used to identify type of lymphoma. Characteristics of monoclonal secretion were assessed with high-resolution electrophoresis in agarose gel with subsequent immunofixation of sera and concentrated urine. Results. Liver involvement was detected in 66 % of patients with HCV-associated CGEV., 34% patients were chronic HCV carriers with persistently normal liver function tests. Common rheumatologic manifestations of HCV-associated CGEV were skin lesions (90%), arthralgia (85%), frequent peripheral nervous system involvement (52%) and glomerulonephritis (38%). Prevalent immunological markers of CGEV associated with HCV were mixed monoclonal cryoglobulinemia with rheumatoid factor activity (62%), rare polyclonal (34%) and olygoclonal (4%) cryoglobulinemia, low levels of С4 compliment fraction (80%). Patients with mixed monoclonal cryoglobulinemia often developed clinical manifestations of Sjögren s syndrome (23 %) and malignant lymphoproliferative diseases (14 %). CGEV is a prognostically adverse sign in HCV infected patients and caused death of 14% patients even in a short period of follow-up (1-2 years).cryoglobulinemic vasculitismixed monoclonal or polyclonal cryoglobulinemiahepatitiscryoglobulinemic glomerulonephritislymphomaкриоглобулинемический васкулитНCV-инфекциякриоглобулинемиягепатиткрио-глобулинемический гломерулонефритлимфомыНCV infection[Ferri C., Zignego A. L., Pileri S. A. Cryoglobulins. J. Clin. Pathol. 2002; 55: 4—13.][Brouet J., Clauvel E., Danon F. et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am. J. Med. 1974; 57: 774—782.][Galli M., Invernizzi F., Monti G. Cryoglobulinaemic vasculitis. In: Ball G. V., Bridges S. L., eds. Vasculitis. 2-nd ed. Oxford: Oxford University Press; 2008: 529—565.][Lamprecht P., Gause A. Gross W. L. Cryoglobulinemic vasculitis. Arthr. and Rheum. 1999; 42 (12): 2507—2516.][Васильев В. И., Пробатова Н. А., Варламова Е. Ю. и др. Прогностическое значение смешанной моноклональной криоглобулинемии при болезни Шегрена. Тер. арх.; 2004; 8: 61—68.][Tedeschi A., Barate C., Minola E., Morra E. Cryoglobulinemia. Blood Rev. 2007; 21 (4): 183—200.][Васильев В. И., Ходарев Н. В., Мач Э. С. и др. Криоглобулинемия при болезни Шегрена. Тер. арх. 1990; 5: 66—70.][Константинова Н. А. Криоглобулины и патология. М.: Медицина; 1999.][Levo Y. Cryoproteins, cryoimmunoglobulinemia and cryofibrinogenemia. Adv. Microcirc. 1982; 10: 73—94.][Tzioufas A. G., Manussakis M. N., Costello M. et al. Cryoglobulinemia in autoimmune rheumatic diseases. Arthr. and Rheum. 1986; 29 (9): 1098—1104.][Steinhardt M. J., Fisher G. S. Essential cryoglobulinemia. Ann. J. Int. Med. 1954; 65: 848—858.][Meltzer M., Franclin E. C Cryoglobulinemia — a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am. J. Med. 1966; 40: 828—836.][Ferri C., Sebastiani M., Giuggioli D. et al. Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival 231 patients. Semin. Arthr. Rheum. 2004; 33 (6): 355—377.][Trejo O., Ramos-Casals M., Garsia-Carrasco M. et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001; 80: 252—262.][Saadoun D., Aaron L., Resche-Rigon M. et al. Cryoglobulinaemic vasculitis in patients coinfected with HIV and hepatitis C virus. AIDS 2006; 20: 871—877.][Goveric P. D., Kassab H. J., Levo Y. et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am. J. Med. 1980; 69: 287—308.][Pawlotsky J.-M., Roudot-Thoraval F., Simmonds P. et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann. Intern. Med. 1995; 122: 169—173.][McMurray R.W., Elbourne K. Hepatitis C virus infection and autoimmunity. Semin. Arthr. Rheum. 1997; 26: 689—701.][Cacoub P., Poynard T., Ghillani P. et al. Extrahepatic manifestations of chronic hepatitis C. Arthr. and Rheum. 1999; 42(10): 2204—2212.][Braun G. S., Horster S., Wagner K. S. et al. Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects. Postgrad. Med. J. 2007; 83: 87—94.][Kayali Z., Buckwold V. E., Zimmerman B. et al. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 31: 978—985.][Weiner S. M., Berg T., Berthold H. et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J. Hepat. 1998; 29: 375—384.][Zignego A. L., Ferri C., Giannini C. et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann. Int. Med. 1996; 124: 31—34.][Zehender G., De Maddalena C., Monti G. et al. HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Clin. Exp. Rheumatol. 1995; 13 (Suppl.): 87—90.][Sinico R.A., Ribero M. L., Fornasieri A. et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. Quart. J. Med. 1995; 88: 805—810.][Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin. Immunopathol. 1997; 19: 111—129.][Saadoun D., Landau D. A., Calabrese L. H., Cacoub P. P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology 2007; 46: 1234—1242.][Ramos-Casals M., Loustaud-Ratti V., De Vita S. et al. Sjoegren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84: 81—89.][Haddad J., Deny P., Munz-Gotheil C. et al. Lymphocytic sialadenitis of Sjoegren’s syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321—323.][Cторожаков Г. И., Никитин И. Г., Лепков С. В. и др. Хронический вирусный гепатит С и лимфопролиферативные заболевания. Клин. перспект. гастроэнтерол., гепатол. 2006; 3: 3—9.][Luppi M., Longo G., Ferrari M. G. et al. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin’s lymphomas without symptomatic cryoglobulinemia. Ann. Oncol. 1998; 9: 495—498.][Gorevic P. D., Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin. Hematol. 1991; 28: 79—94.][Васильев В. И., Логвиненко О. А., Пробатова Н. А. и др. Роль биопсии околоушной слюнной железы в ранней диагностике лимфом при болезни Шегрена. Тер. арх. 2009; 6: 20—27.][Cacoub P., Saadoun D., Limal N. et al. Hepatitis C virus infection and mixed cryoglobulinaemiavasculitis: a revive of neurological complications. AIDS 2005; 19 (Suppl. 3): 128—134.][Сacoub P., Renou C., Rosenthal E. et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltimore) 2000; 79: 47—56.][Ferri C., La Givita L., Cirafisi C. et al. Peripheral neurepathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J. Rheumatol. 1992; 19: 889—895.][Cassato M., Saadoun D., Marchetti A. et al. Central nervous system involvement in hepatitis C virus cryoglobulinemiavasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J. Rheumatol. 2005; 32: 484—488.][Beddhu S., Bastacky S., Johnson J. P. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 2002; 81: 398—409.][Bombardieri S., Paoletti P., Ferri C. et al. Lung involvement in essential mixed cryoglobulinemia. Am. J. Med. 1979; 66: 748—756.][Ferri C., LaCivita L., Fazzi P. et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatic C virus infection. Br. J. Rheumatol. 1997; 36 (3): 360—365.][Manganelli P., Salaffi F., Subiaco S. et al. Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. Br. J. Rheumatol. 1996; 35 (10): 978—982.][Подымова С. Д. Болезни печени. М.: Медицина; 2005. 60—65.][Пальшина С. Г., Васильев В. И. Криоглобулинемический васкулит. Науч.-практ. ревматол. 2010; 4: 59—66.][Pietrogrande M., De Vita S., Zignego A. et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Review. Autoimmun. Rev. 2011; 1: 1—11.]